Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Return on Sales (2021 - 2025)

Historic Return on Sales for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Q3 2025 value amounting to 1.03%.

  • Rhythm Pharmaceuticals' Return on Sales rose 2800.0% to 1.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.1%, marking a year-over-year increase of 12000.0%. This contributed to the annual value of 2.0% for FY2024, which is 3800.0% up from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Return on Sales of 1.03% as of Q3 2025, which was up 2800.0% from 0.96% recorded in Q2 2025.
  • Rhythm Pharmaceuticals' 5-year Return on Sales high stood at 1250.0% for Q1 2021, and its period low was 129.16% during Q2 2021.
  • Its 5-year average for Return on Sales is 51.64%, with a median of 2.43% in 2023.
  • Within the past 5 years, the most significant YoY rise in Rhythm Pharmaceuticals' Return on Sales was 1242100bps (2022), while the steepest drop was -12850700bps (2022).
  • Quarter analysis of 5 years shows Rhythm Pharmaceuticals' Return on Sales stood at 27.99% in 2021, then skyrocketed by 83bps to 4.83% in 2022, then soared by 64bps to 1.72% in 2023, then soared by 40bps to 1.03% in 2024, then grew by 0bps to 1.03% in 2025.
  • Its last three reported values are 1.03% in Q3 2025, 0.96% for Q2 2025, and 1.51% during Q1 2025.